T1	Condition 355 362	disease
T2	Condition-Name 355 362	disease
E1	Condition:T1 Name:T2
T5	Condition 1115 1142	superior vena cava syndrome
T6	Condition-Name 1115 1142	superior vena cava syndrome
E5	Condition:T5 Name:T6
T7	Condition 1090 1113	spinal cord compression
T8	Condition-Name 1090 1113	spinal cord compression
E7	Condition:T7 Name:T8
T9	Condition 1172 1181	disorders
T10	Condition-Name 1172 1181	disorders
E9	Condition:T9 Name:T10
T11	Condition 1052 1060	diabetes
T12	Condition-Name 1052 1060	diabetes
E11	Condition:T11 Name:T12 Severity:T71
T13	Eq-Operator 28 52	equal to or greater than
A1	Eq-Operator-Value T13 GTEQ
T14	Eq-Temporal-Unit 56 61	years
A2	Eq-Temporal-Unit-Value T14 year
T15	Age 65 68	age
E12	Age:T15 Eq-Comparison:E13
T16	Eq-Value 53 55	18
T17	Eq-Value 302 303	3
T18	Eq-Value 308 309	4
T20	Eq-Comparison 28 61	equal to or greater than 18 years
E13	Eq-Comparison:T20 Operator:T13 Temporal-Unit:T14 Value:T16
T21	Condition 135 147	solid tumors
E2	Condition:T21 Name:T22
T22	Condition-Name 135 147	solid tumors
T23	Modifier 115 134	advanced refractory
E4	Modifier:T23 Modifies:T22
T24	Procedure 89 98	cytologic
E6	Procedure:T24 Name:T25
T25	Procedure-Name 89 98	cytologic
T26	Procedure 75 85	Histologic
E8	Procedure:T26 Name:T27
T27	Procedure-Name 75 85	Histologic
T28	Or 86 88	or
E10	Or:T28 Arg:E8 Arg2:E6
R1	Found-By Arg1:E2 Arg2:E6	
R2	Found-By Arg1:E2 Arg2:E8	
T29	Procedure 165 174	treatment
E14	Procedure:T29 
T30	Negation 153 155	no
E15	Negation:T30 Negates:E14
T31	Assertion 175 182	options
E16	Assertion:T31 Asserted:E14
A3	Assertion-Type-Value E16 hypothetical
R3	Treatment-For Arg1:E14 Arg2:E2	
T32	Condition 233 258	reduced general condition
E17	Condition:T32 Name:T33
T33	Condition-Name 233 258	reduced general condition
T34	Coreference 213 229	advanced disease
E18	Coreference:T34 Refers-To:E2
T35	Condition 260 294	Eastern Cooperative Oncology Group
E19	Condition:T35 Name:T36
T36	Condition-Name 260 294	Eastern Cooperative Oncology Group
T37	Condition 296 300	ECOG
E20	Condition:T37 Name:T38 Stage:E21
T38	Condition-Name 296 300	ECOG
T39	Eq-Comparison 302 309	3 and 4
E21	Eq-Comparison:T39 Value:T17 Value2:T18
R4	Abbrev-Of Arg1:E20 Arg2:E19	
R5	Equivalent-To Arg1:E19 Arg2:E17	
T3	Modifier 345 354	evaluable
E3	Modifier:T3 Modifies:T2
T4	Modifier 331 341	measurable
E22	Modifier:T4 Modifies:T2
T19	Or 342 344	or
E23	Or:T19 Arg:E22 Arg2:E3
T40	Observation 472 485	blood samples
E24	Observation:T40 Specimen:T41
T41	Observation-Specimen 472 477	blood
T42	Observation 489 503	tissue samples
E25	Observation:T42 Specimen:T43
T43	Observation-Specimen 489 495	tissue
T44	Or 486 488	or
E26	Or:T44 Arg:E24 Arg2:E25
T45	Assertion 456 463	able to
E27	Assertion:T45 Asserted:E24
A4	Assertion-Type-Value E27 hypothetical
T46	Procedure 508 511	NGS
E28	Procedure:T46 Name:T47
T47	Procedure-Name 508 511	NGS
T48	Procedure 513 539	Next Generation Sequencing
E29	Procedure:T48 Name:T49
T49	Procedure-Name 513 539	Next Generation Sequencing
R6	Abbrev-Of Arg1:E28 Arg2:E29	
R7	Using Arg1:E28 Arg2:E25	
R8	Using Arg1:E28 Arg2:E24	
T50	Observation 574 588	tissue samples
E30	Observation:T50 Specimen2:T51
T51	Observation-Specimen 574 580	tissue
T52	Observation-Specimen 564 569	blood
T53	Observation 564 569	blood
E31	Observation:T53 Specimen:T52
T54	Or 570 573	and
E32	Or:T54 Arg:E31 Arg2:E30
T55	Assertion 589 603	should be able
E33	Assertion:T55 Asserted:E30
A5	Assertion-Type-Value E33 hypothetical
T56	Condition 691 712	organ system function
E34	Condition:T56 Name:T57 Polarity:T58
T57	Condition-Name 691 712	organ system function
T58	Polarity 673 681	Adequate
A6	Polarity-Value T58 normal
T59	Procedure 765 768	MTB
E35	Procedure:T59 Name:T60
T60	Procedure-Name 765 768	MTB
T61	Procedure 770 791	Molecular Tumor Board
E36	Procedure:T61 Name:T62
T62	Procedure-Name 770 791	Molecular Tumor Board
R9	Abbrev-Of Arg1:E35 Arg2:E36	
T63	Procedure 742 751	treatment
E37	Procedure:T63 
R10	Using Arg1:E37 Arg2:E35	
T64	Assertion 728 733	could
E38	Assertion:T64 Asserted:E37
A7	Assertion-Type-Value E38 hypothetical
T65	Risk 986 991	risks
E39	Risk:T65 Severity:T66
T66	Severity 962 969	serious
A8	Severity-Value T66 severe
T67	Modifier 971 985	uncontrollable
E40	Modifier:T67 Modifies:E39
T68	Condition 1027 1035	diseases
E41	Condition:T68 Name:T69
T69	Condition-Name 1027 1035	diseases
T70	Or 1013 1015	or
E42	Or:T70 Arg:E39 Arg2:E41
T71	Severity 1045 1051	severe
A9	Severity-Value T71 severe
R11	Example-Of Arg1:E11 Arg2:E41	
T72	Condition 1062 1077	thyroid disease
E43	Condition:T72 Name:T73
T73	Condition-Name 1062 1077	thyroid disease
R12	Example-Of Arg1:E43 Arg2:E41	
T74	Condition 1079 1088	infection
E44	Condition:T74 Name:T75
T75	Condition-Name 1079 1088	infection
R13	Example-Of Arg1:E44 Arg2:E41	
T76	Modifier 1160 1171	psychiatric
E45	Modifier:T76 Modifies:T10
T77	Modifier 1144 1156	neurological
E46	Modifier:T77 Modifies:T10
T78	Or 1157 1159	or
E47	Or:T78 Arg:E46 Arg2:E45
R14	Example-Of Arg1:E7 Arg2:E41	
R15	Example-Of Arg1:E5 Arg2:E41	
R16	Example-Of Arg1:E9 Arg2:E41	
T79	Study 1236 1241	study
E48	Study:T79 Stability:T80
T80	Stability 1198 1204	affect
A10	Stability-Value T80 change
R17	Caused-By Arg1:T80 Arg2:E41	
